AMPK is mitochondrial medicine for neuromuscular disorders

AI Mikhail, SY Ng, SR Mattina, V Ljubicic - Trends in Molecular Medicine, 2023 - cell.com
Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), and spinal
muscular atrophy (SMA) are the most prevalent neuromuscular disorders (NMDs) in children …

Mitochondrial dysfunction in repeat expansion diseases

A Giménez-Bejarano, E Alegre-Cortés… - Antioxidants, 2023 - mdpi.com
Repeat expansion diseases are a group of neuromuscular and neurodegenerative
disorders characterized by expansions of several successive repeated DNA sequences …

The Role of Exercise in Maintaining Mitochondrial Proteostasis in Parkinson's Disease

J Li, Y Xu, T Liu, Y Xu, X Zhao, J Wei - International Journal of Molecular …, 2023 - mdpi.com
Parkinson's disease (PD) is the second most common rapidly progressive
neurodegenerative disease and has serious health and socio-economic consequences …

Towards the identification of biomarkers for muscle function improvement in myotonic dystrophy type 1

A Aoussim, C Légaré, MP Roussel… - Journal of …, 2023 - content.iospress.com
Background: Myotonic dystrophy type 1 (DM1) is the most common muscular dystrophy in
adults. In DM1 patients, skeletal muscle is severely impaired, even atrophied and patients …

The role of mitophagy in metabolic diseases and its exercise intervention

S Tang, Y Geng, Q Lin - Frontiers in Physiology, 2024 - frontiersin.org
Mitochondria are energy factories that sustain life activities in the body, and their dysfunction
can cause various metabolic diseases that threaten human health. Mitophagy, an essential …

Secondary mitochondrial dysfunction across the spectrum of hereditary and acquired muscle disorders

G Mak, M Tarnopolsky, JQ Lu - Mitochondrion, 2024 - Elsevier
Mitochondria form a dynamic network within skeletal muscle. This network is not only
responsible for producing adenine triphosphate through oxidative phosphorylation, but also …

Muscle physiology and its relations to the whole body in health and disease

K Groeneveld - Acta Physiologica, 2024 - Wiley Online Library
Over the past years, researchers increased awareness of the connection of muscle tissue to
the rest of the human body and of the possibilities to tweak the muscles' metabolism in order …

[PDF][PDF] Митохондриальная динамика и значение ее нарушений в развитии детских болезней. Часть I. Физиологические и неврологические аспекты

ВС Сухоруков, ТИ Баранич, АВ Егорова… - Российский вестник …, 2024 - researchgate.net
Динамика митохондриальных преобразований в клетке вызывает в последние годы
все больший интерес как представителей фундаментальной науки, так и …

Altérations métaboliques dans la dystrophie myotonique de type I-Une piste thérapeutique potentielle

L Lessard, L Gallay, R Mounier - médecine/sciences, 2024 - medecinesciences.org
La dystrophie myotonique de type I (DM1) est une maladie génétique responsable d'une
altération multi-systémique de l'épissage alternatif. En conséquence, de nombreuses voies …

Investigating the Therapeutic Potential of AMP-Activated Protein Kinase in Myotonic Dystrophy Type 1

N Misquitta - 2024 - ruor.uottawa.ca
Abstract Myotonic dystrophy type 1 (DM1) is the most prevalent form of adult-onset muscular
dystrophy and arises from a CTG trinucleotide repeat expansion mutation in the dystrophia …